# Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human

> **NCT02129621** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 42 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **PROCEDURE:** Urinary and blood lipococalin levels determination
- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT02129621
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129621, "Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02129621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*